ESTABROOK CAPITAL MANAGEMENT – Eli Lilly and Company Transaction History
ESTABROOK CAPITAL MANAGEMENT portfolio value:
$3.21M
portfolio value
ESTABROOK CAPITAL MANAGEMENT quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -4.10% | -425 shares | -146.53K | $323.35 | 9.93K |
| Q2 2022 | share | Decrease | -1.44% | -151 shares | 348.79K | $324.23 | 10.35K |
| Q1 2022 | share | Decrease | -6.04% | -675 shares | -79.81K | $286.37 | 10.50K |
| Q4 2021 | share | Decrease | -14.91% | -1.95K shares | 52.41K | $277.25 | 11.18K |
| Q3 2021 | share | Decrease | -2.67% | -360 shares | -62.52K | $230.3 | 13.14K |
| Q2 2021 | share | Decrease | -1.24% | -170 shares | 544.69K | $228.04 | 13.5K |
| Q1 2021 | share | Decrease | -2.15% | -300 shares | 195.13K | $184.81 | 13.67K |
| Q4 2020 | share | Decrease | -1.29% | -182 shares | 263.91K | $166.32 | 13.97K |
| Q3 2020 | share | Decrease | -4.09% | -603 shares | -327.69K | $145.05 | 14.15K |
| Q2 2020 | share | Decrease | -0.67% | -100 shares | 361.79K | $160.1 | 14.75K |
| Q1 2020 | share | Decrease | -0.34% | -50 shares | 101.72K | $134.64 | 14.85K |
| Q4 2019 | share | Decrease | -0.67% | -100 shares | 280.95K | $126.91 | 14.90K |
| Q3 2019 | share | Increase | +0.74% | 110 shares | 27.79K | $107.36 | 15.00K |
| Q2 2019 | share | Decrease | -0.67% | -100 shares | -295.53K | $105.74 | 14.89K |
| Q1 2019 | share | Decrease | -1.79% | -274 shares | 178.82K | $123.17 | 14.99K |
| Q4 2018 | share | Decrease | -3.04% | -479 shares | 77.01K | $109.26 | 15.26K |
| Q3 2018 | share | Decrease | -1.10% | -175 shares | 331.20K | $100.8 | 15.74K |
| Q2 2018 | share | Decrease | -2.75% | -450 shares | 91.93K | $79.72 | 15.92K |
| Q1 2018 | share | Decrease | -1.81% | -302 shares | -141.59K | $71.78 | 16.37K |
| Q4 2017 | share | 0.00% | 0 shares | -18.00K | $77.79 | 16.67K | |
| Q3 2017 | share | 0.00% | 0 shares | 54.02K | $78.29 | 16.67K | |
| Q2 2017 | share | 0.00% | 0 shares | -30.18K | $74.85 | 16.67K | |
| Q1 2017 | share | Decrease | -31.02% | -7.5K shares | -375.53K | $76 | 16.67K |
| Q4 2016 | share | 0.00% | 0 shares | -162.21K | $66.02 | 24.17K | |
| Q3 2016 | share | Decrease | -0.41% | -100 shares | 28.63K | $71.57 | 24.17K |
| Q2 2016 | share | 0.00% | 0 shares | 163.61K | $69.79 | 24.27K | |
| Q1 2016 | share | Decrease | -1.22% | -300 shares | -322.64K | $63.39 | 24.27K |